Mitral Valve Disease clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
open to eligible people ages 18 years and up
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team, and in patients with functional mitral regurgitation (FMR) on guideline directed medical therapy (GDMT)
Orange, California and other locations
Our lead scientists for Mitral Valve Disease research studies include Antonio Frangieh, MD.
Last updated: